Drug Information for Femring (estradiol acetate vaginal ring) (Warner Chilcott (US), LLC): CONTRAINDICATIONS

  • Femring should not be used in women with any of the following conditions:

    • Undiagnosed abnormal genital bleeding.
    • Known, suspected, or history of breast cancer.
    • Known or suspected estrogen-dependent neoplasia.
    • Active deep vein thrombosis, pulmonary embolism or history of these conditions.
    • Active arterial thromboembolic disease (for example, stroke and myocardial infarction) or a history of these conditions.
    • Known liver dysfunction or disease.
    • Known or suspected pregnancy.
  • Drug Information Provided by National Library of Medicine (NLM).